Different sampling time points and Blinding [Bioanalytics]

posted by Pharma_88 – India, 2020-12-11 05:22 (320 d 02:34 ago) – Posting: # 22138
Views: 1,238

Dear all,

Please provide your suggestion for below concern.

for the bioequivalence studies, Analyst is always blind despite of regulatory requirement. By keeping different sampling time points i.e. 20 time-points for test and 22 time points for reference, whether analyst will blind in this condition?


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Activity
 Admin contact
21,758 posts in 4,550 threads, 1,545 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Wednesday 08:56 CEST (Europe/Vienna)

There ain’t no rules around here!
We’re trying to accomplish something!    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5